Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

Exclusion Criteria

• •Sensitivity or allergy to penicillins or cephalosporins or inability to take oral medications
• •Presence of tympanostomy tubes, ventilation tube or perforated tympanic membrane, in either ear
• •Treatment with any anti-infective agent within 3 days prior to the study or treatment with a long-acting injectable antimicrobial agent (e.g. , penicillin G benzathine) within 4 weeks prior to the study
• •Concomitant infection, that requires additional antimicrobial therapy
• •Presence of a disease, complicating factor (e.g., mastoiditis), or structural abnormality that would preclude evaluation of the patient's therapeutic response